Records containing: Sudden Hearing Loss
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20Efficacy and Safety of Trans-Round Window Membrane Intracochlear Steroid Delivery in Patients With Complete Sudden Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2026-04-01Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss: A Multicenter, Randomized, Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-03-25Clinical Phase I and IIa Trials of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2026-03-16Truway Health Inner Ear Regeneration & Hearing Restoration Trial
-
CLINICAL_TRIALS study record update · 2025-11-19Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-26Prospective Cohort Study of Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
-
CLINICAL_TRIALS study record update · 2025-03-20Evaluation of Different Anesthesia Methods to Reduce Pain From Intratympanic Injections: A Prospective, Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-06-21Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2023-04-21A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Multicenter Study to Evaluate the Efficacy of FX-322 Administered by Intratympanic Injection in Adults With Acquired Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2022-11-04Prognosis of Vestibular Dysfunction in Patients With Idiopathic Sudden Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2022-05-25A Phase 1b, Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Multicenter, Safety Study of FX-322 Administered by Intratympanic Injection in Adults With Age-Related Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2022-02-01A Phase 1b, Prospective, Randomized, Double-Blind, Placebo- Controlled, Single-Dose, Multicenter, Safety Study of FX-322 Administered by Intratympanic Injection in Adults With Severe Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2021-05-26What is the Tympanic Membrane Healing Time After Insertion of a Gelfoam PE Tube?
-
CLINICAL_TRIALS study record update · 2020-06-29The Effect of Patient's Position After Intra-tympanic Injection on the Amount of Fluid in the Middle Ear
-
CLINICAL_TRIALS study record update · 2020-06-01Prevalence of Obstructive Sleep Apnea Syndrome in Patients With a History of Sudden Sensorineural Hearing Loss
-
CLINICAL_TRIALS study record update · 2020-05-12The Effect of Patient's Position After Intra-tympanic Injection on the Amount of Fluid in the Middle Ear
-
CLINICAL_TRIALS study record update · 2019-12-10The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2019-07-24Vestibular Prognosis Assessment of the Idiopathic Sudden Sensorineural Hearing Loss With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids
-
CLINICAL_TRIALS study record update · 2018-10-17The Evaluation of the Ischemia-modified Albumin Levels in the Patients With Sudden Sensorineural Hearing Loss